Search for: "In re Eli"
Results 921 - 940
of 1,367
Sorted by Relevance
|
Sort by Date
31 Mar 2011, 5:14 am
Bob has worked with notable clients, including Coca-Cola, Eli Lilly, Nickelodeon, Showtime, Verizon and WebMD. [read post]
22 Mar 2010, 2:53 pm
Elie’s matchmaking attempt fell flat. [read post]
1 Mar 2011, 9:41 am
Isn’t this exactly why Elie is so angry at Ave Maria? [read post]
12 Feb 2012, 6:00 am
Re-create the smell of ex-boyfriend. [read post]
5 Jan 2008, 6:28 am
Go ahead and lay the 10 points if you're a Charger fan. [read post]
31 May 2011, 8:38 pm
Novo Nordisk (Orange Book Blog) Silenor (Doxepin) – US: Somaxon files patent infringement lawsuit against Par Pharmaceuticals over bid to market generic Silenor (GenericsWeb) Strattera (Atomoxetine) – US: Eli Lilly files patent infringement complaint against Zydus in response to Para IV certification (Patent Docs) Zemplar (Paricalcitol) – US: Abbott Lab’s files patent infringement complaint against Sandoz in response to Para IV certification (Patent Docs) Ziana… [read post]
13 Nov 2014, 11:26 am
The consolidated Actos case in Louisiana is In Re Actos (Pioglitazone) Products Liability Litigation, 11-md-02299, U.S. [read post]
21 May 2012, 4:36 am
However, it has been proven time and again that when people know how to correctly re-direct an elder with dementia, or de-escalate their agitation, those meds are not necessary. [read post]
22 Oct 2010, 8:12 am
Elie Note: Fresh allegations about Clarence Thomas = the results of Anita Hill praying on what to do about Ginni Thomas. [read post]
13 Nov 2013, 10:01 pm
Optaflexx, sold by Eli Lilly’s Elanco animal-health unit, is considered less effective than Zilmax. [read post]
11 Nov 2011, 8:21 am
We told you about this back in January, but today we’re going to get a little more in-depth with his vitriol. [read post]
26 Aug 2009, 6:12 am
(Korea IP Law Blog) US: Senate Agriculture/FDA Appropriations Bill amendment seeks to streamline development and regulation of products for rare and neglected diseases (FDA Law Blog) US: Professor Grabowski’s economic analysis of data exclusivity for follow-on biologic drugs (Patent Docs) US: Follow-on biologics news briefs: President Obama wants to speed up introduction of generic drugs; biosimilars pose ‘limited threat’; Amgen CEO says biologic manufacturers will… [read post]
27 Aug 2014, 5:30 am
Now that we’re firmly in the information age, it’s time for trade secrets to join their peers. [read post]
3 Apr 2015, 7:01 am
Actos Bladder Cancer Lawsuits Continue to Increase There are more than 4,000 federal personal injury, product liability lawsuits pending against Takeda Pharmaceuticals and Eli Lilly. [read post]
9 Jan 2012, 6:18 am
They’re not really going to ask for an exemption for themselves, are they? [read post]
21 Sep 2011, 11:02 am
See, Elie? [read post]
15 Mar 2022, 4:23 am
And that’s because it’s not, at least not in the minds of the people whose view of constitutional rights is that they’re fine until they involve speech that is just so obviously bad that it can’t be tolerated. [read post]
4 Mar 2011, 1:16 pm
If anything, this current fight is only round one, with a second partisan fight over legislative re-districting yet to come. [read post]
24 Feb 2023, 4:14 pm
Question: If a document is not considered acceptable, and the attorney re-submits the requested documents, on average, how long does the NVC take to review the new evidence? [read post]
10 Feb 2010, 4:26 am
na sunulmak üzere gerekçeli iptal ba? [read post]
